Loading...

ViaDerma, Inc.

VDRMPNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.001
$0.00(0.00%)

ViaDerma, Inc. (VDRM) Company Profile & Overview

Explore ViaDerma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

ViaDerma, Inc. (VDRM) Company Profile & Overview

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEODr. Christopher A Otiko

Contact Information

310 496 5744
4640 Admiralty Way, Marina del Rey, CA, 90292

Company Facts

IPO DateOct 31, 2014
CountryUS
Actively Trading

Frequently Asked Questions